Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Roche Holding AG Basel American Depositary Shares
(OP:
RHHBY
)
40.59
USD
+0.09 (+0.22%)
Official Closing Price
Updated: 4:42 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,185,800
Open
40.32
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
40.50
Today's Range
39.80 - 40.63
52wk Range
35.04 - 47.15
Shares Outstanding
6,830,797,784
Dividend Yield
2.26%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Genentech’s Actemra Becomes the First Biologic Therapy Approved by the FDA for Slowing the Rate of Decline in Pulmonary Function in Adults With Systemic Sclerosis-Associated Interstitial Lung Disease,
March 04, 2021
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Actemra® (tocilizumab) subcutaneous injection for slowing...
From
Business Wire News Releases
Spark Therapeutics Further Strengthens Technical Expertise with Appointment of Cynthia Pussinen as Chief Technical Officer
February 25, 2021
From
GlobeNewswire News Releases
Performance
YTD
-7.50%
-7.50%
1 Month
-7.12%
-7.12%
3 Month
-5.04%
-5.04%
6 Month
-7.50%
-7.50%
1 Year
-3.43%
-3.43%
More News
Read More
Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment of COVID-19 in Japan
February 19, 2021
From
GlobeNewswire News Releases
Genentech Announces Results From Evrysdi (risdiplam) Study in Infants With Type 1 Spinal Muscular Atrophy (SMA) Published in New England Journal of Medicine
February 24, 2021
From
Business Wire News Releases
Roche's Tocilizumab Injection Wins FDA Approval For Lung Disease
March 05, 2021
Tags
Lung Disease
RHHVF
RHHBY
From
Benzinga
OTC Markets Group On The Importance Of Investor Relations During A Pandemic
March 02, 2021
Tags
Markets
OTC Markets Group
Adidas
From
Benzinga
Regeneron's COVID-19 Antibody Cocktail Wins EU Positive Opinion
February 26, 2021
Tags
Market News
RHHBF
Health Care
From
Benzinga
Roche Reports Positive Evrysdi Data From Dose-Finding Part Of Spinal Muscular Atrophy Trial
February 25, 2021
Tags
News
Phase 3 Trial
Biotech
From
Benzinga
Should You Buy Invitae Stock?
March 04, 2021
Tags
ROKU
ILMN
TSLA
From
Motley Fool
Opthea Outlines OPT-302 Pivotal Study Designs In Chronic Eye Disorder
February 24, 2021
Tags
REGN
General
OPT
From
Benzinga
Why Turning Point Is Turning Heads
February 23, 2021
Tags
Market News
TPTX
AMGN
From
Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.